Pacira Pharmaceuticals (PCRX) PT Raised to $24 at Barclays
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $25.36 +0.79%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $24.00 (from $17.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Leerink Starts Pacira Pharmaceuticals (PCRX) at Market Perform
- Ametek Inc. (AME) PT Raised to $290 at BNP Paribas Exane
- Inspire Medical Systems (INSP) PT Raised to $80 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
